Advertisement
Canada markets close in 4 hours 47 minutes
  • S&P/TSX

    22,177.06
    +69.98 (+0.32%)
     
  • S&P 500

    5,251.47
    +2.98 (+0.06%)
     
  • DOW

    39,726.58
    -33.50 (-0.08%)
     
  • CAD/USD

    0.7378
    +0.0005 (+0.07%)
     
  • CRUDE OIL

    82.73
    +1.38 (+1.70%)
     
  • Bitcoin CAD

    96,566.82
    +1,996.31 (+2.11%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,234.90
    +22.20 (+1.00%)
     
  • RUSSELL 2000

    2,129.37
    +15.02 (+0.71%)
     
  • 10-Yr Bond

    4.1940
    -0.0020 (-0.05%)
     
  • NASDAQ

    16,391.03
    -8.49 (-0.05%)
     
  • VOLATILITY

    13.01
    +0.23 (+1.80%)
     
  • FTSE

    7,972.26
    +40.28 (+0.51%)
     
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     
  • CAD/EUR

    0.6832
    +0.0027 (+0.40%)
     

Canadian drugmaker Concordia says CEO to step down

(Reuters) - Canadian generic-drug maker Concordia International Corp said on Friday that Chief Executive Mark Thompson would step down after a replacement is found. Thompson's resignation comes at a time when the company is trying to raise cash to cut its $3 billion debt as it faces curbs on drug pricing from governments and companies. Reuters reported earlier this month that the company was discussing alternatives to a leveraged buyout, including selling a minority stake to a private equity firm. The talks came after negotiations about selling the company failed to produce a deal that would be acceptable to its board, sources told Reuters. A search process for a new CEO is underway, the company said. Concordia, which had a market capitalization of C$270.1 million ($202.46 million) as of Thursday close, sells drugs for conditions ranging from malaria to heart disease. Concordia's Toronto-listed shares were up 18 percent at C$6.16. The company's U.S.-listed shares were up 19 percent at $4.73. (Reporting by Anet Josline Pinto and Akankshita Mukhopadhyay in Bengaluru; Editing by Anil D'Silva and Don Sebastian)